Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Medical Devices — Retail - Devices. Per the activity note to the FY2024 annual report, the company supplies medical devices wholesale and retail.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| 3,386 | 3,078 | 4,379 | 4,552 | 5,255 | 8,419 | 3,629 | 2,727 | -3.0% | |
| Total COGS | 2,454 | 2,183 | 3,146 | 2,929 | 3,172 | 6,075 | 2,500 | 1,925 | -3.4% |
| Gross Profit | 932 | 895 | 1,233 | 1,623 | 2,084 | 2,344 | 1,129 | 801 | -2.1% |
| Gross Margin | 27.5% | 29.1% | 28.2% | 35.6% | 39.6% | 27.8% | 31.1% | 29.4% | |
| 729 | 824 | 936 | 1,006 | 1,082 | 1,304 | 1,131 | 1,030 | +5.1% | |
| EBITDA | 203 | 71 | 297 | 617 | 1,001 | 1,040 | 2 | 229 | nmf |
| EBITDA Margin | 6.0% | 2.3% | 6.8% | 13.5% | 19.1% | 12.4% | 0.1% | 8.4% | |
| Total D&A | 64 | 60 | 42 | 45 | 62 | 74 | 81 | 104 | +7.2% |
| EBIT / Operating Income | 139 | 11 | 256 | 571 | 939 | 966 | 83 | 333 | nmf |
| Total Interest Income | 0 | 2 | 12 | 6 | 0 | 2 | 1 | 26 | +50.5% |
| Total Interest Expense | 0 | 205 | 202 | 189 | 241 | 192 | 107 | 164 | -3.6% |
| 35 | 39 | 63 | 151 | 105 | 203 | 83 | 33 | nmf | |
| Profit Before Tax | 104 | 230 | 2 | 237 | 804 | 978 | 107 | 439 | nmf |
| Total Income Tax | 0 | 0 | 0 | 0 | 19 | 57 | 46 | 55 | +43.6% |
| Net Profit / (Loss) | 168 | 24 | 229 | 300 | 1,168 | 959 | 35 | 318 | nmf |
| Net Margin | 5.0% | 0.8% | 5.2% | 6.6% | 22.2% | 11.4% | 1.0% | 11.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →